Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay.

Curr Oncol · 2023 · PMC10604986 · PMID 37887543

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a statistical trendp = 0.08so close (0.05 < p ≤ 0.1)

This difference showed a statistical trend after analysis for TP53 mutations ( p = 0.08). 3.4.

also in 959 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.